Treatment decisions based on gene mutations vs. disease origin
Design clinical trial in an era of personalized oncology
Histopathology vs. Modern Molecular DX
Gene signatures for disease classification
Gene to drug development
CTC as a prognostic and treatment monitoring tool
Small molecules vs. Abs
Past Events
The 1st International Congress on Controversies in Personalized Oncology (CONPO) 2013 - 07-10 Mar 2013, SOFIA Barcelona, Spain (34024)
Important
Please, check "The International Congress on Controversies in Personalized Oncology (CONPO)" official website for possible changes, before making any traveling arrangements
